Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report)’s share price fell 1.9% during trading on Monday . The company traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.34). 49,264 shares were traded during trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.34).
Mereo BioPharma Group plc (MPH.L) Price Performance
The company has a fifty day simple moving average of GBX 26.50 and a two-hundred day simple moving average of GBX 26.50. The stock has a market capitalization of £89.76 million and a price-to-earnings ratio of -0.21. The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
See Also
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Why Invest in High-Yield Dividend Stocks?
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
